NYNZERA Trademark

Trademark Overview

On Friday, April 11, 2014, a trademark application was filed for NYNZERA with the United States Patent and Trademark Office. The USPTO has given the NYNZERA trademark a serial number of 79148810. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 30, 2021. This trademark is owned by Novo Nordisk A/S. The NYNZERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for haemostasis management
nynzera

General Information

Serial Number79148810
Word MarkNYNZERA
Filing DateFriday, April 11, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 30, 2021
Registration Number4669345
Registration DateTuesday, January 13, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 28, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for haemostasis management

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk A/S
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBagsværd DK2880
DK
Party NameNovo Nordisk A/S
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBagsværd DK2880
DK
Party NameNovo Nordisk A/S
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBagsværd DK2880
DK

Trademark Events

Event DateEvent Description
Tuesday, August 16, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, July 20, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, July 20, 2022INVALIDATION PROCESSED
Wednesday, March 30, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 30, 2021CANCELLED SECTION 71
Sunday, June 7, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 21, 2015FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 21, 2015FINAL DISPOSITION PROCESSED
Monday, April 13, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 13, 2015REGISTERED-PRINCIPAL REGISTER
Saturday, November 8, 2014NOTIFICATION PROCESSED BY IB
Tuesday, October 28, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 22, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 22, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 8, 2014NOTICE OF PUBLICATION
Wednesday, September 24, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 22, 2014ASSIGNED TO LIE
Tuesday, September 9, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 1, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 1, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 1, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 1, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 16, 2014REFUSAL PROCESSED BY IB
Friday, July 25, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 25, 2014REFUSAL PROCESSED BY MPU
Thursday, July 24, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 23, 2014NON-FINAL ACTION WRITTEN
Wednesday, July 23, 2014ASSIGNED TO EXAMINER
Tuesday, July 22, 2014APPLICATION FILING RECEIPT MAILED
Wednesday, July 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 11, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

nynzera management haemostasis preparations pharmaceutical